PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-05-22 (5)

Date Title Company
22-May-2026 Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX) Businesswire